Make money doing the work you believe in
We're seeing major advances vs pancreatic cancer. Today data for daraxonrasib
Context for this first-in-class molecular glue nejm.org/doi/full/10.10…
May 6
at
9:22 PM
We're seeing major advances vs pancreatic cancer. Today data for daraxonrasib
Context for this first-in-class molecular glue nejm.org/doi/full/10.10…